CVS Health Corporation (CVS)
CVS Health Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 10, 2024 to Discuss Your Rights - CVS
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
CVS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds CVS Health Corporation Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against CVS Health Corporation ("CVS" or "the Company") (NYSE:CVS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired CVS securities between May 3, 2023, and April 30, 2024, inclusive (the "Class Period").
CVS Health Stock Drops After Cutting Profit Forecast Again
CVS Health said pressure in its benefits segment prompted another cut to its full-year forecast. Here's what you need to know.
Contact Levi & Korsinsky by September 10, 2024 Deadline to Join Class Action Against CVS Health Corporation (CVS)
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
CVS cuts outlook, plans $2B cost-cutting effort
CVS said Wednesday that it's launching a multi-year productivity initiative. It also cut its outlook for the year as its health care benefits segment continues to face pressure.
Compared to Estimates, CVS Health (CVS) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CVS Cuts Its Full-Year Profit Outlook, Again
CVS Health (CVS) shares lost ground in early trading Wednesday after the pharmacy giant slashed its 2024 earnings guidance again amid increased medical costs and announced the departure of the head of its Aetna unit.
CVS Health (CVS) Beats Q2 Earnings, Narrows '24 EPS Outlook
CVS Health (CVS) delivers a year-over-year improvement in revenues, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments.
CVS Health (CVS) Beats Q2 Earnings Estimates
CVS Health (CVS) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.74 per share. This compares to earnings of $2.21 per share a year ago.
CVS Health Corp shares under pressure after guidance downgrade
Shares in CVS Health Corp (NYSE:CVS) were under pressure pre-market after it lowered full-year forecasts due to medical costs. The impact of the news was partially offset by a second-quarter earnings print that exceeded expectations.
CVS Stock Falls Despite Earnings Beat. Blame Medicare.
The healthcare giant cut its 2024 earnings outlook, citing higher medical costs in its insurance business.
CVS's stock drops after a revenue miss and lowered profit outlook, amid challenges in health care benefits
Shares of CVS Health Corp. CVS, +0.92% dropped 2.3% in premarket trading Wednesday, after the drugstore chain beat second-quarter profit expectations but missed on revenue and lowered its full-year outlook, citing weakness in its health care benefits business. Net income fell to $1.77 billion, or $1.41 a share, from $1.90 billion, or $1.48 a share, in the same period a year ago.
